No abstract available
Keywords:
Adjuvant; HER2+; Lapatinib; Rash; Toxicity.
Publication types
-
Case Reports
-
Clinical Trial, Phase II
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects*
-
Breast Neoplasms / drug therapy*
-
Drug Eruptions* / epidemiology
-
Drug Eruptions* / pathology
-
Female
-
Humans
-
Lapatinib
-
Middle Aged
-
Paclitaxel / administration & dosage
-
Paclitaxel / adverse effects
-
Quinazolines / administration & dosage
-
Quinazolines / adverse effects
-
Trastuzumab / administration & dosage
-
Trastuzumab / adverse effects
Substances
-
Quinazolines
-
Lapatinib
-
Trastuzumab
-
Paclitaxel